Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Digestive Diseases and Sciences|March 22, 2023
Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver DiseaseLuis C Bertot, Gary P Jeffrey, Bastiaan de Boer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2021
Serum Fibrosis Tests Guide Prognosis in Metabolic Dysfunction-Associated Fatty Liver Disease Patients Referred From Primary CareZhengyi Wang, Luis Calzadilla Bertot, Gary P Jeffrey, et al.
Journal of Medical Imaging and Radiation Oncology|February 6, 2025
Safety and Efficacy of Selective Internal Radiation Therapy for Portal Vein Tumour Thrombus in Advanced Hepatocellular Carcinoma: A Single-Centre Experience in AustraliaWilliam Ormiston, Shaun Samuelson, Matthys Van Wyk, et al.
Internal Medicine Journal|April 11, 2026
Annual magnetic resonance cholangiopancreatography surveillance outcomes in individuals with primary sclerosing cholangitisGary Dezhi Zhang, Chloe Attree, Nazneen Irani, et al.
Journal of Gastroenterology and Hepatology|February 10, 2020
The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolizationMichael C Wallace, Shaun Samuelson, Tiffany Khoo, et al.
Digestive Diseases and Sciences|August 24, 2019
Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional TherapyMichael C Wallace, Kenny Sek, Roslyn J Francis, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 14, 2025
Analysis of the impact of female sex and muscle mass on serum creatinine and waitlist priority for liver transplantationShivangi Gupta, Angus W Jeffrey, Zhengyi Wang, et al.
Scandinavian Journal of Gastroenterology|October 19, 2020
Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitisStuart K Roberts, Simone I Strasser, Amanda J Nicoll, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2025
Surviving Hepatitis C-Understanding Death and Survival Beyond CurePaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Drug and Alcohol Review|August 2, 2024
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)Paul J Clark, Patricia C Valery, Simone I Strasser, et al.
Pageof 6